Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.51 USD | +6.81% |
|
+14.09% | +9.61% |
07-15 | Checkpoint Therapeutics, GC Cell Collaborate on Cancer Research; Shares Rise | MT |
07-15 | GC Cell and Checkpoint Therapeutics Advance Collaborative Cancer Research | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.61% | 95.58M | |
+22.15% | 46.56B | |
+44.47% | 41.67B | |
-2.37% | 41.16B | |
+33.84% | 32.4B | |
+20.42% | 28.18B | |
-6.35% | 28.1B | |
+48.83% | 14.52B | |
+45.00% | 13.74B | |
+0.06% | 12.17B |
- Stock Market
- Equities
- CKPT Stock
- News Checkpoint Therapeutics, Inc.
- Checkpoint Therapeutics Resubmits Biologics License Application for Cosibelimab, Launches $12 Million Direct Share Offering